Reminder: Sangamo Presents at JP Morgan Today 12:30 pm EST

Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced today that Edward Lanphier, Sangamo's president and chief executive officer, will provide an update on the Company's clinical and preclinical ZFP Therapeutic^® programs and upcoming milestones, as well as an overview of Sangamo's business strategy at 9:30 am PT on Tuesday, January 12^th, at the 34^th Annual J.P. Morgan Healthcare Conference. The conference will be held from January 11-14 in San Francisco, CA